Translational Addiction Medicine

转化成瘾医学分支（TAMB）的创建始于本财政年度，因此，工作主要集中在规划阶段，以提供必要的资源（人力、空间和物质），支持其明确的使命。在Leggio博士的领导下，该新分支的行政、管理、临床和科学基础设施、目标和愿景的创建和发展已经开始，计划在下一个财政年度开始时完成启动阶段，届时TAMB将达到稳定状态。TAMB团队将在马里兰州巴尔的摩约翰霍普金斯湾景校区的国家药物滥用研究所校内研究计划进行基础科学工作、住院和门诊人体研究和/或大型调查和在线研究。与NIDA IRP的其他分支机构合作，与Bayview校区的NIA IRP合作，以及与主校区的其他IRP合作（例如NIAAA，NIMH，NHGRI，NIDDK，NIMHD等）以及与学术中心的合作将是TAMB团队的使命和愿景的关键。

The creation of the Translational Addiction Medicine Branch (TAMB) began during this fiscal year, therefore efforts have been primarily focused in the planning stage to put the necessary resources (human, space and material) in place to support its well-defined mission. Under the leadership of Dr. Leggio, the creation and development of the administrative, management, clinical and scientific infrastructure, goals and vision of this new Branch has started and the plan is to complete its start-up phase at the beginning of next fiscal year, when TAMB will reach its steady-state. The TAMB teams will conduct basic science work, in-patient and outpatient human research and/or large survey and online studies at the National Institute on Drug Abuse Intramural Research Program,Johns Hopkins Bayview campus, Baltimore, MD. Collaborations with the other Branches of the NIDA IRP, with the NIA IRP in the Bayview campus, as well as with other IRPs in the main campus (e.g. NIAAA, NIMH, NHGRI, NIDDK, NIMHD, and others) and with academic Centers will be key to the mission and vision of the TAMB teams.